Publicador de contenidos

Investigación, Eliminación de la malaria

MalTransc

Transcriptional regulation of adaptation and developmental decisions in malaria parasites: from epigenetic variation to directed transcriptional responses

Foto: Canva
Duración
01/06/2020 - 31/01/2024
Coordinador
Alfred Córtes Closas
Financiadores
Ministerio de Ciencia e Innovación - Agencia Estatal De Investigación. Reference: PID2019-107232RB-I00 Call: Proyectos I+D+i 2019 - Modalidades Retos Investigación» y Generación de Conocimiento

Transcriptional regulation plays a fundamental role in the biology of the protozoan parasite Plasmodium falciparum, which is responsible for the most severe forms of human malaria. Both developmental progression through a complex life cycle and adaptation to changes in the conditions of the environment are mainly regulated at the transcriptional level.

We and others have established that transcriptional variation regulated at the epigenetic level within isogenic parasite populations plays and adaptive role and regulates processes such as immune evasion, solute transport, erythrocyte invasion and sexual conversion, among others. More recently, we have demonstrated that malaria parasites can also produce rapid transcription factor-driven protective responses to changes in their environment. In spite of enormous progress in recent years, many fundamental questions about the molecular mechanisms regulating epigenetic variation and directed transcriptional responses in malaria still remain unanswered. In this project we will address some of these questions.

First, we will characterize the role of different genetic elements (e.g. promoters and coding sequences) in determining that a gene undergoes clonal variation regulated at the epigenetic level. Since heterochromatin underlies the epigenetic silencing of clonally variant genes, we will test the role of these elements in heterochromatin nucleation, spreading and maintenance. For this aim, we will mainly use CRISPR-Cas9 technology to manipulate the parasite genome and chromatin immunoprecipitation followed by quantitative PCR (ChIP-qPCR) or massive sequencing (ChIP-seq) analysis. We will also test the hypothesis that heterochromatin does not form de novo when clonally variant genes are silenced or dismantles completely when they are activated, but rather heterochromatin contracts or spreads from nearby reservoirs (the accordion model).

To identify the specific enzymes involved in heterochromatin formation and removal, we will use catalytically inactive Cas9 fusions (dCas9) and a proximity labeling approach (BioID). We will also study in detail the chromatin alterations, including histone post-translational modifications, associated with activation of clonally variant genes and with activation in response to changes in the environment.

In addition to studying general aspects of epigenetic variation, we will focus on the gene pfap2-g and the process that it controls, sexual conversion. This process is of enormous importance in parasite biology, because sexual conversion determines the formation of transmission stages. In the case of directed transcriptional responses, we will mainly focus on the gene pfap2-hs and the heat shock response.

Last, to identify new important phenotypes and processes linked to epigenetic variation, we will test the hypothesis that silencing of clag3 genes is linked to formation of dormant stages, which play a key role in parasite resistance to the frontline drug artemisinin. Altogether, this project is expected to contribute important new insight on the molecular mechanisms that regulate transcription, parasite adaptation to the conditions of the environment, and conversion into sexual forms.

Expected technical and international scientific impact

Malaria remains a major scourge for humanity, as it still kills almost half a million children and produces debilitating disease in 200 million people every year. In the current context of climate change, increased human mobility and political instability in many regions, how malaria will affect the world in the following years is largely unpredictable. Malaria may come back to areas such as Europe where it was eliminated some decades ago. At the moment, the fight against malaria is at a crossroads. Major progress in reducing the impact of malaria since year 2000 has now stalled, and progress is threatened by the emergence of artemisinin resistance. In the following years, we may see malaria go up again, as happened several times in history, or we can get back on track and progress further towards reduction and eventually erradication.

Although there are different views on whether or not this can be achieved within a fixed deadline, there is consensus that development of new tools and strategies based on a better knowledge of fundamental parasite biology is essential. This project fits with the idea of generating high quality new knowledge on the biology of Plasmodium falciparum, the parasite responsible for the most severe forms of human malaria and the vast majority of malaria deaths. It focuses on fundamental processes in parasite biology, such as the transcriptional mechanism of adaptation and survival upon changes in the environment in general, and on two more specific processes: resistance to heat shock mimicking host fever episodes, and sexual conversion.

Regarding resistance to heat shock, periodic fever is the most characteristic clinical symptom of malaria. Thus, it is surprising that until now nothing was known about how malaria parasites survive host fever episodes. Our identification of the transcription factor PfAP2-HS opens the way for a full understanding of the process.

Regarding sexual conversion, there is an increased interest on malaria transmission stages (gametocytes) and sexual conversion, because only by preventing transmission (in addition to curing patients) can malaria be eliminated. In this context, our research on pfap2-g is highly relevant, as this gene provides an ideal molecular marker to monitor how malaria elimination interventions affect parasite investment in transmission, and to define the human malaria infectious reservoir that needs to be targeted. In this regard, in addition to the identification of pfap2-g, our recent research has identified another molecular marker with potential valuable applications in epidemiological studies. Furthermore, one of the objectives in this project addresses a potential new mechanism of artemisinin resistance, the major challenge to current malaria control efforts.

Altogether, our research is basic in nature but focuses on processes of major public health importance and can yield new markers for molecular surveillance or reveal important new targets for drug development. Of note, while this is not a drug development project, many epigenetic factors and other proteins involved in transcription are validated drug targets for which a wealth of inhibitors and structural knowledge is available, mainly from cancer research. A better knowledge of the molecular machinery involved in the heat shock response or sexual conversion may lead to the development of new types of antimalarial drugs that interfere with these essential processes.

Total Funding

278.300 €


 

 

Nuestro equipo

Coordinator

ISGlobal Team

Ver más

Otros proyectos

Ver proyectos pasados

NHEPACHA

Nuevas Herramientas para el Diagnóstico y la Evaluación del Paciente con Enfermedad de Chagas

Estudio inmunológico de la vacuna RTS,S

Estudio de correlatos de protección frente a la malaria después de la vacunación con RTS,S/AS01E: Una evaluación inmunológica exhaustiva en el ensayo clínico de Fase III, doble ciego, aleatorizado, multicéntrico con un grupo control

Euroleish.net

Control of Leishmaniasis. From bench to bedside and community

GREPIMER

Grup de recerca en patología importada i malaties emergents i re-emergents

TESEO

Nuevos regímenes de quimioterapia y biomarcadores para la enfermedad de Chagas

ASINTMAL

Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults

ADAM

Administración masiva y focal de fármacos antimaláricos para avanzar hacia la eliminación de la malaria en Mozambique: acelerando la implementación de programas y políticas

MULTIPLY

MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention

Science4Pandemics

Citizens engagement digital platform for collective intelligence in pandemics

HIDDENVIVAX

Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria

EpiGen

Building Scalable Pathogen Genomic Epidemiology in Ethiopia

SMART

Identifying Severe Malaria with a new Aptamer-based Rapid diagnostic Test

GenMoz

P. falciparum genomic intelligence in Mozambique

BOHEMIA

Broad One Health Endectocide-based Malaria Intervention in Africa

RESPONSE

Mechanisms of the transcriptional responses to changes in the environment in the malaria parasite Plasmodium falciparum

VivaxEVTalk

Extracellular Vesicles as Intercellular Communicators and Biomarkers of Cryptic Erythrocytic Infections in Plasmodium vivax malaria

VaMonoS

Unravelling the heterogoneity and function of monocytes in vaccination and immunity to malaria

CLIMSOCTRYPBOL

Insight on climate and social participatory research for integral management of vectorborne zoonosis caused by Trypanosoma cruzi and Leishmania spp. in the Bolivian Gran Chaco.

SexMal

Social affairs and sex in P. falciparum: implications for malaria elimination

MENA Migrant Health

Transforming data collection and surveillance to drive migrant health research, care and policy

MESA

La Alianza Científica para la Erradicación de la Malaria (MESA) tiene como objetivo avanzar en la ciencia de la erradicación de la malaria.